Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

September 25 2023 - FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show

FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show
Daiichi Sankyo reports positive results from trial of breast cancer therapy
Novo Nordisk and Valo to research cardiometabolic treatments
AbbVie ends I-Mab partnership for CD47 antibody compounds
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen

Reuters

Tuesday, September 26, 2023 - 10:23am

tags:

Biogen, Eisai, Japan, Leqembi, Alzheimer's disease

Emcure Pharma plans to launch $400-500 million IPO in 2024

Mint

Tuesday, September 26, 2023 - 10:21am

tags:

Emcure Pharmaceuticals, IPOs

MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services

BioSpace

Tuesday, September 26, 2023 - 10:18am

tags:

MilliporeSigma, MRNA, CTDMOs

Elderly exclusion: Clinical trials still fall short enrolling older adults

Pharma Voice

Tuesday, September 26, 2023 - 10:15am

tags:

elderly, clinical trials

Alfasigma To Acquire Intercept Pharma For $19 Per Share In Cash

RTT News

Tuesday, September 26, 2023 - 10:13am

tags:

Intercept Pharma, M&A, Alfasigma, NASH

J&J shines light on key role in multiple myeloma care team, vowing to raise awareness and offer support

Fierce Pharma

Tuesday, September 26, 2023 - 10:10am

tags:

JNJ, Multiple Myeloma, pharma marketing

Coherus hits FDA hurdles for PD-1 drug, Neulasta biosimilar on-body injector

Fierce Pharma

Monday, September 25, 2023 - 7:56pm

tags:

Coherus Biosciences, Neulasta, biosimilars, FDA, Junshi Biosciences

Enovis inks €800M deal for Italian orthopedics player Lima

Fierce Biotech

Monday, September 25, 2023 - 7:51pm

tags:

Enovis, Medtech, M&A, Orthopedics, Lima

Novartis confirms Sandoz spin-off for October 4, 2023

Reuters

Monday, September 25, 2023 - 7:45pm

tags:

Novartis, Sandoz, spinoffs

Roche condemns 'act of counterfeiting' as authorities in Pakistan crack down on unapproved Avastin use

Fierce Pharma

Monday, September 25, 2023 - 7:42pm

tags:

Roche, Avastin, Pakistan, drug counterfeiting

Pfizer restarts production at tornado-hit plant—but supply squeezes are expected to persist

Fierce Pharma

Monday, September 25, 2023 - 7:41pm

tags:

Pfizer, North Carolina, tornado, drug manufacturing, drug shortages

AcuraStem and Takeda Partner to Revolutionize ALS Treatment

Best Stocks

Monday, September 25, 2023 - 7:40pm

tags:

Takeda, AcuraStem, ALS, AS-202

FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show

BioPharma Dive

Monday, September 25, 2023 - 11:52am

tags:

Brainstorm Cell Thearpaueics, ALS, stem cells, FDA, NurOwn

BridgeBio makes $250M in securities sale while planning acoramidis commercial launch

Fierce Biotech

Monday, September 25, 2023 - 11:51am

tags:

BridgeBio Pharma, acoramidis

Daiichi Sankyo reports positive results from trial of breast cancer therapy

Clinical Trials Arena

Monday, September 25, 2023 - 11:47am

tags:

Daiichi Sankyo, clinical trials, Dato-DXd, breast cancer

Lupin acquires five brands and associated trademark rights from Menarini

Pharmaceutical Business Review

Monday, September 25, 2023 - 11:42am

tags:

Lupin, Menarini

Novartis eyes first-line use of Lutathera after trial win

Pharmaphorum

Monday, September 25, 2023 - 11:41am

tags:

Novartis, radioligands, clinical trials, neuroendocrine tumors, Lutathera

Generics maker VistaPharm recalls ulcer med on bacteria contamination fears

Fierce Pharma

Monday, September 25, 2023 - 11:39am

tags:

VistaPharm, product recalls, generics

Novo Nordisk and Valo to research cardiometabolic treatments

Reuters

Monday, September 25, 2023 - 10:16am

tags:

Novo Nordisk, Valo Health, R&D, artificial intelligence, cardiometabolic diseases

Eli Lilly receives UK approval for ulcerative colitis treatment

Biopharma Reporter

Monday, September 25, 2023 - 10:13am

tags:

Eli Lilly, NICE, UK, ulcerative colitis, mirikizumab

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Klick Health launches new healthcare venture studio

Medtech earnings reports: insights from major players' Q4 results

Key compliance issues for medtech firms transitioning to data-enabled solutions

Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

EXCLUSIVE: The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021

Drug Channels

A Clear Path to Education Affordability Requires Meeting Patients Where They Are

Drug Channels

NEW: The Drug Channels 2024 Video Webinar Series

Drug Channels

Do Plan Sponsors Understand How Their PBMs Make Money?

Drug Channels

Informa Connect’s Patient Support Services Congress

Drug Channels

How Payers Are Reacting to Insulin Price Changes

Drug Channels

White Bagging Update 2023: Saving Money or Shifting Costs?

Drug Channels

Available for Preorder: The 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

Drug Channels

What Pharmaceutical Manufacturers Value Most from a Hub

Drug Channels